Magante, Nieva T.
HRN: 16-84-23 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/10/2022
LEVOFLOXACIN 500MG (TAB)
06/10/2022
06/17/2022
PO
500 Mg
Od
Acute Pyelonephritis
Waiting Final Action
Indication: EmpiricEmpirical De-escalation Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: No Wrong Dose Wrong Dose
Overall appropriateness: No Wrong Dose